Drug Type Gene editing |
Synonyms- |
Target |
Action agonists |
Mechanism SFTPB agonists(surfactant protein B agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Congenital Deficiency of Pulmonary Surfactant Protein B | Preclinical | Canada | 01 May 2023 |